Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes

    ... OBJECTIVES: Thirty to 80 per cent of patients with myelodysplastic syndromes (MDS) become transfusion-dependent and are at risk for red ...

    Research Article last updated 02/03/2017 - 11:00am.

  2. Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDS) represent a clonal hematopoietic stem cell disorder ...

    Research Article last updated 02/01/2017 - 8:17am.

  3. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

    ... Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms ocurring ...

    Research Article last updated 02/01/2017 - 8:15am.

  4. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

    ... PURPOSE: We have observed an increasing incidence of myelodysplastic syndromes (MDS) in the geographic area of Western Greece during the past ...

    Research Article last updated 02/03/2017 - 10:41am.

  5. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

    ... Myelodysplastic syndromes (MDS) are a group of acquired hematopoietic stem cell disorders ...

    Research Article last updated 01/24/2017 - 7:25am.

  6. Jing Fang, MD, PhD

    ... Mechanisms linking p62/SQSTM1 to the Evolution of Myelodysplastic Syndrome Original ... A major complication of myelodysplastic syndromes (MDS) is worsening cytopenias due to bone marrow failure . ...

    Grant Recipient last updated 01/12/2018 - 9:35am.

  7. Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment

    ... times for people with acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) could be improved by adding a biological drug ... acute myeloid leukemia (AML) myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/29/2017 - 10:32am.

  8. Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate

    ... INTRODUCTION: Patients with myelodysplastic syndromes (MDS) differ from those with other transfusion-dependent ...

    Research Article last updated 01/26/2017 - 10:17am.

  9. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly

    ... Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic diseases ...

    Research Article last updated 12/09/2015 - 1:30pm.

  10. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... therapy in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are unclear. Methods We enrolled 84 adult patients with AML ...

    Research Article last updated 01/26/2017 - 10:07am.